Renaissance Technologies’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Renaissance Technologies’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-409,284	Closed	-$178K	–	4534
2022 Q4	$178K	Buy	409,284 +47,284	+13%	+$15.3K	﹤0.01%	3462
2022 Q3	$101K	Sell	362,000 -98,394	-21%	-$33.7K	﹤0.01%	3597
2022 Q2	$166K	Sell	460,394 -106,759	-19%	-$44.2K	﹤0.01%	3715
2022 Q1	$380K	Sell	567,153 -86,547	-13%	-$73.5K	﹤0.01%	3360
2021 Q4	$843K	Sell	653,700 -158,903	-20%	-$282K	﹤0.01%	2772
2021 Q3	$1.76M	Buy	+812,603	New	+$1.77M	﹤0.01%	2187
2021 Q2	–	Sell	-481,707	Closed	-$1.26M	–	3889
2021 Q1	$1.26M	Buy	+481,707	New	+$1.36M	﹤0.01%	2505
2020 Q4	–	Sell	-440,923	Closed	-$2.04M	–	3822
2020 Q3	$2.04M	Sell	440,923 -245,000	-36%	-$809K	﹤0.01%	2121
2020 Q2	$1.93M	Buy	685,923 +217,800	+47%	+$699K	﹤0.01%	2202
2020 Q1	$1.14M	Buy	468,123 +147,700	+46%	+$533K	﹤0.01%	2362
2019 Q4	$1.64M	Buy	320,423 +42,400	+15%	+$235K	﹤0.01%	2413
2019 Q3	$1.8M	Sell	278,023 -51,800	-16%	-$357K	﹤0.01%	2337
2019 Q2	$2.06M	Buy	329,823 +7,435	+2%	+$56.6K	﹤0.01%	2311
2019 Q1	$3.43M	Buy	322,388 +24,250	+8%	+$241K	﹤0.01%	2037
2018 Q4	$2.38M	Buy	298,138 +36,675	+14%	+$529K	﹤0.01%	2139
2018 Q3	$5.06M	Buy	261,463 +98,513	+60%	+$1.79M	0.01%	1788
2018 Q2	$2.95M	Sell	162,950 -78,775	-33%	-$1.16M	﹤0.01%	2070
2018 Q1	$2.57M	Buy	241,725 +215,175	+810%	+$3.46M	﹤0.01%	2200
2017 Q4	$1.12M	Buy	26,550 +2,237	+9%	+$100K	﹤0.01%	2620
2017 Q3	$1.34M	Buy	+24,313	New	+$4.1M	﹤0.01%	2463
2016 Q4	–	Sell	-8,725	Closed	-$977K	–	3535
2016 Q3	$977K	Buy	+8,725	New	+$1.05M	﹤0.01%	2579

Other funds holding SIOX

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Renaissance Technologies's SIOX Position: Q1 2023 in Review

Renaissance Technologies sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 409,284 shares — an estimated $178K sold.

Renaissance Technologies first reported a position in SIOX in Q3 2016 and held it in 21 quarters. The position peaked at $5.06M in Q3 2018. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

Renaissance Technologies reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Renaissance Technologies sold 409,284 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $178K.
Renaissance Technologies first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2016 and held it in 21 quarters.
Renaissance Technologies's Sio Gene Therapies Inc. Common Stock position peaked at $5.06M in Q3 2018.
4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.